TAK-573-1501

Clinical Trial Grant

Duke Scholars

Principal Investigator Yubin Kang Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Takeda Development Center Americas, Inc

Start Date

August 31, 2022

End Date

September 14, 2027

Administered By

Duke Cancer Institute

Awarded By

Takeda Development Center Americas, Inc

Start Date

August 31, 2022

End Date

September 14, 2027